Diazyme, Maccura to Launch Covid-19 Molecular Diagnostic
Diazyme is partnering with Maccura Biotechnology USA to launch an FDA EUA approved SARS-COV-2 RT-PCR diagnostics test.
Read MorePosted by Melanie Hamilton-Basich | Aug 1, 2020 | Company News, Covid 19, Molecular Diagnostics |
Diazyme is partnering with Maccura Biotechnology USA to launch an FDA EUA approved SARS-COV-2 RT-PCR diagnostics test.
Read MorePosted by Laurie Bonner | Jul 31, 2020 | Covid 19, Immunoassay |
What do they really mean as the world yearns for a return to normal life?
Read MorePosted by Laurie Bonner | Jul 31, 2020 | Covid 19, Uncategorized |
The case report describes pathologic findings of vasculitis of the small vessels of the heart, which likely represents multisystem inflammatory syndrome.
Read MorePosted by Laurie Bonner | Jul 31, 2020 | Covid 19, Uncategorized |
The new technique from Quest Diagnostics speeds the process of extracting viral RNA from specimens.
Read MorePosted by Melanie Hamilton-Basich | Jul 31, 2020 | Molecular Diagnostics |
Amsbio offers a comprehensive range of end-to-end services for exosome purification, characterization, and engineering.
Read More